BioAgilytix Announces Promotion of Corinna Fiorotti, Ph.D. to Scientific Officer and Key Accounts Director

MARCH 26, 2019—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has announced that Corinna Fiorotti, Ph.D., has been promoted to Scientific Officer and Key Accounts Director for the company. Moving from her former position as Business Development Director, Dr. Fiorotti will take a leading role in developing and managing customer accounts throughout North America.

“Corinna has been an invaluable part of our Business Development team for the last three years. Not only is she uniquely equipped with the deep scientific expertise required to understand our customers’ toughest bioanalytical challenges, but she also has a genuine passion for developing strategies to solve them,” said Jim Datin, President and Chief Executive Officer of BioAgilytix. “In her new role as Scientific Officer, she will have the opportunity to share her scientific perspective with more customers across the US, and I have every confidence their projects will benefit in turn.”

As an accomplished scientist, Dr. Fiorotti has more than 15 years of in-laboratory experience to call upon in her discussions with customers. She obtained her Ph.D. in Microbiology and Immunology from the University of New Hampshire and completed a postdoctoral fellowship in Molecular Genetics at Harvard Medical School, where she was awarded several NIH grants to investigate polysaccharide genetics of Bacteroides fragilis where her work was featured on the cover of Nature. She later joined Eyetech Pharmaceuticals, where her team investigated the mechanism of disease in age-related-macular degeneration and was involved in the approval of Macugen®. Just prior to joining BioAgilytix, Dr. Fiorotti was a Senior Research Scientist at Pfizer, where she was responsible for developing cell-based assays for the detection of neutralizing antibodies, as well as ADA and PK assays for both pre-clinical and clinical support and performing sample analysis.

“It is always exciting to meet with clients and learn about their innovative drug development programs, and each new account brings unique challenges to tackle,” said Dr. Fiorotti. “Because I come from a scientific background, I’m able to offer solutions to customers’ problems that I’ve seen in the lab firsthand. I am looking forward to continuing to serve new clients with a ‘science-first’ focus and to act as a strategic partner in their efforts to bring new biotherapeutics to patients in need.”


About BioAgilytix

BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. With laboratory locations in North Carolina’s Research Triangle area and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e. product release testing, stability testing, etc.).

BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to many of the top global pharmaceutical and biotech companies. For more information, visit

Media Contact:
Carla Nieser
Vovéo Marketing Group
610.240.0400, x 118

Share This